<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04282993</url>
  </required_header>
  <id_info>
    <org_study_id>AN01</org_study_id>
    <nct_id>NCT04282993</nct_id>
  </id_info>
  <brief_title>Wearable Devices for Secondary Prevention of Ischemic Stroke</brief_title>
  <official_title>Wearable Devices for Secondary Prevention of Ischemic Stroke</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Campus Bio-Medico University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Campus Bio-Medico University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Ischemic stroke is an important cause of death and disability in Western countries. Different
      risk factors have been identified such as hypertension, diabetes, dyslipidemia, smoke, atrial
      fibrillation, obesity, and sedentary. The aim of this study is to evaluate the feasibility of
      an approach based on the use of wearable devices for the identification and reduction of risk
      factors in patients with previous history of ischemic stroke or transient ischemic attack.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 16, 2019</start_date>
  <completion_date type="Anticipated">June 30, 2022</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Compliance of patients to at-home follow-up by means of wearable devices</measure>
    <time_frame>1 month</time_frame>
    <description>Number of measurements actually performed in comparison to number of expected measurements</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Atrial fibrillation Detection Rate</measure>
    <time_frame>1 month</time_frame>
    <description>Percentage of subjects with atrial fibrillation detected within 1 month of follow-up</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Prevalence of Recurrent Stroke or Transient Ischemic Attack</measure>
    <time_frame>1 month</time_frame>
    <description>Prevalence of subjects with recurrent stroke or Transient Ischemic Attack within 1 month of follow-up</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Stroke, Ischemic</condition>
  <condition>Atrial Fibrillation</condition>
  <arm_group>
    <arm_group_label>Wearable Devices Monitoring</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients will be provided with wearable devices for at-home monitoring heart rhythm and rate, blood pressure, pulse oximetry, quality and quantity of sleep, and pace counting.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Standard of Care Monitoring</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients will be evaluated by periodical clinical visits.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Wearable devices for identifying and measuring risk factors for ischemic stroke</intervention_name>
    <description>Identifying and monitoring cerebrovascular risk factors using wearable devices</description>
    <arm_group_label>Wearable Devices Monitoring</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Standard of care monitoring</intervention_name>
    <description>Periodical medical examinations</description>
    <arm_group_label>Standard of Care Monitoring</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age greater than or equal 50 years

          -  Recent transient ischemic attack or minor stroke

        Exclusion Criteria:

          -  Patients with significant cognitive impairment

          -  Patients dependent in the instrumental activities of daily life

          -  Patients not able to respect the frequency of monitoring program

          -  Patients with history of atrial fibrillation
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>50 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Vincenzo Di Lazzaro, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Campus Bio-Medico University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Vincenzo Di Lazzaro, MD</last_name>
    <phone>+3906225411220</phone>
    <email>v.dilazzaro@unicampus.it</email>
  </overall_contact>
  <location>
    <facility>
      <name>Universit√† Campus Bio-Medico di Roma</name>
      <address>
        <city>Roma</city>
        <state>RM</state>
        <zip>00128</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Vincenzo Di Lazzaro</last_name>
      <phone>+3906225411220</phone>
      <email>v.dilazzaro@unicampus.it</email>
    </contact>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>February 2020</verification_date>
  <study_first_submitted>February 19, 2020</study_first_submitted>
  <study_first_submitted_qc>February 24, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">February 25, 2020</study_first_posted>
  <last_update_submitted>February 25, 2020</last_update_submitted>
  <last_update_submitted_qc>February 25, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">February 27, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Campus Bio-Medico University</investigator_affiliation>
    <investigator_full_name>Di Lazzaro Vincenzo</investigator_full_name>
    <investigator_title>Head of Neurology</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stroke</mesh_term>
    <mesh_term>Atrial Fibrillation</mesh_term>
    <mesh_term>Ischemia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

